What is SOLV's five-year median P/E?

10.7x. Half of SOLV's weekly readings since February 2025 were higher and half were lower. This page has 88 weekly readings, from Feb 24, 2025 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares SOLV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Solventum (SOLV) valuation

Health Care

$81.85

Latest weekly close · Market cap $14.2B

Within its usual range

Solventum's P/E of 10.0x is lower than 56% of its weekly readings since February 2025 (as of Oct 29, 2026).

Forward P/E 11.8× (analyst estimates, not ranked).

Weekly P/E since February 2025

P/E each weekMiddle half of its readingsMedian 10.7×

Median: 10.7×
Low to high: 7.1× to 36.2×
Versus median: -6%
History starts: February 2025

P/E

44thpercentile

of its weekly readings since February 2025

Growth, last 12 months vs the year before

Revenue: -1%decelerating
EPS: +276%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

SOLV P/E at each year-end
Year-end	P/E	5-year percentile	P/S	EV/Sales	EV/EBITDA
Dec 29, 2025	9.1×	6	1.7×	2.1×	6.4×

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare SOLV with peers

Health Care peers of SOLV on P/E
Stock	P/E	Versus its own history	5-year percentile
DOCSDoximity Inc	40.3×	Within its usual range	34
VEEVVeeva Systems	52.0×	Below its usual range	21
AAgilent Technologies	35.8×	Historically high	91
ABBVAbbVie	80.8×	Above its usual range	76
ABTAbbott Laboratories	33.1×	Above its usual range	70

Appears in

Sector: Health Care
Screens: Stocks Below Their 5-Year Median P/E
Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on SOLV

No articles about SOLV yet. How valuation percentiles work

Loading peers and related research…

About this history

What is SOLV's current P/E?: Solventum's P/E of 10.0x is lower than 56% of its weekly readings since February 2025 (as of Oct 29, 2026).
What is SOLV's five-year median P/E?: 10.7x. Half of SOLV's weekly readings since February 2025 were higher and half were lower. This page has 88 weekly readings, from Feb 24, 2025 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares SOLV only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.